Isavuconazole as Primary Antifungal Prophylaxis in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study

Prithviraj Bose, David McCue, Sebastian Wurster, Nathan P. Wiederhold, Marina Konopleva, Tapan M. Kadia, Gautam Borthakur, Farhad Ravandi, Lucia Masarova, Koichi Takahashi, Zeev Estrov, Musa Yilmaz, Naval Daver, Naveen Pemmaraju, Kiran Naqvi, Caitlin R. Rausch, Kayleigh R. Marx, Wei Qiao, Xuelin Huang, Carol A. BivinsSherry A. Pierce, Hagop M. Kantarjian, Dimitrios P. Kontoyiannis

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Isavuconazole as Primary Antifungal Prophylaxis in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science